Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis

Overview of attention for article published in Vaccines, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 16,131 followers.

RT @ActiveBuildings: New study: Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Er…

RT @ActiveBuildings: New study: Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Er…

RT @ActiveBuildings: New study: Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Er…

RT @ActiveBuildings: New study: Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Er…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.